Asda to sell OTC asthma inhalers – News-Medical.net


Healthcare Today

Asda to sell OTC asthma inhalers
News-Medical.net
Lead Asthma Nurse Cher Piddock said: "If people are using their blue reliever more than twice a week, it can be a sign that their asthma is out of control, which could put them at risk of a life-threatening asthma attack. "It is therefore crucial that
Asthma inhalers to be sold over the counterHealthcare Today
Over-The-Counter Asthma Inhalers Sold At Asda SupermarketHuffington Post UK

all 4 news articles »

View full post on asthma – Google News

Supermarkets to sell asthma inhalers over the counter to patients without a … – Daily Mail


Daily Mail

Supermarkets to sell asthma inhalers over the counter to patients without a
Daily Mail
Asthma inhalers are set go on sale in supermarkets for the first time, allowing sufferers access to the drugs without going to see their doctor. Grocery giant Asda announced last night that it plans to begin selling the blue reliever inhalers over the
ASTHMA RELIEF INHALERS GO ON SALE AT ASDAExpress.co.uk

all 2 news articles »

View full post on asthma – Google News

Nycomed and Orion to sell generic Advair and Symbicort – Pharma Times

Nycomed and Orion to sell generic Advair and Symbicort
Pharma Times
The firms have signed an agreement which covers Orion's combination products for the treatment of asthma and chronic obstructive pulmonary disease, delivered by its new Easyhaler dry powder inhaler. In particular, Orion is developing copies of GSK's
Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPDReuters (press release)

all 6 news articles »

View full post on asthma – Google News

Goldman Sachs downgrades Glaxo to “sell” – BusinessWeek

Goldman Sachs downgrades Glaxo to "sell"
BusinessWeek
A Goldman Sacks analyst says GlaxoSmithKline's stock is overvalued as the British drugmaker prepares to face lower sales of its best-selling product, the asthma inhaler Advair. Goldman analyst Mark Beards notes the London-based drugmaker's shares have
Search Stocks To Watch TodayBarron’s (blog)
Goldman Sachs downgrades Glaxo to "sell"Forbes

all 7 news articles »

View full post on asthma – Google News

Goldman Sachs downgrades Glaxo to “sell” – Forbes

Goldman Sachs downgrades Glaxo to "sell"
Forbes
AP , 05.31.11, 10:57 AM EDT WASHINGTON — A Goldman Sacks analyst says GlaxoSmithKline's stock is overvalued as the British drugmaker prepares to face lower sales of its best-selling product, the asthma inhaler Advair. Goldman analyst Mark Beards notes
Goldman Downgrades GSK as Growth Won't Support ValuationBarron’s (blog)
Goldman Sachs downgrades Glaxo to "sell"CBS MoneyWatch.com

all 10 news articles »

View full post on asthma – Google News

Investor group to sell Asthmatx to Boston Scientific – Trading Markets (press release)


Daily Rosetta

Investor group to sell Asthmatx to Boston Scientific
Trading Markets (press release)
The addition of Asthmatx's products will allow Boston Scientific to expand its reach to patients suffering the effects of severe asthma.
Boston Scientific to Acquire AsthmatxPR Newswire (press release)
Boston Scientific Corporation To Buy Asthmatx Inc. For US$443 MillionMedical News Today
Boston Scientific Locks Down Asthma Co Asthmatx For $443.5 Mln (BSX)Comtex Smartrend
domain-B –The Associated Press –Motley Fool
all 146 news articles »

View full post on asthma – Google News